David Scadden
CIK 1707715 · last filed 2025-11-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$518.6K
Companies
4
Total Filings
34
Lifetime Open-Market Net
$17.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGIO | Director | 17,603 | $29.46 | $518.6K | -$81.5K | 21 | 2025-11-14 |
| EDIT | Director | — | $2.50 | — | $0 | 7 | 2025-06-10 |
| CARM | Director | — | $0.00 | — | $0 | 1 | 2024-07-01 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Director | 802,074 | $11.19 | $8.98M | $99.0K | 5 | 2022-06-30 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-04 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2018-03-20 | AGIO | Buy (P) | +200 | $16.7K | EDGAR |
| 2017-06-15 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2017-05-31 | AGIO | Grant (A) | — | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.